Much has changed in the last 20 years in understanding how an individual’s DNA predicts common diseases, according to Sir Peter Donnelly, who cofounded in 2014 the company Genomics, of which he is CEO, in Oxford, England.

The key areas both nationally and globally are AI, cybersecurity, digital health transformation and workforce development, says Tom Leary, HIMSS SVP and head of government relations.